Latest Strategy News

Botala Energy’s Pitse Pilot well 3.5B at the Serowe CBM Project in Botswana has reached total depth, intersecting coal seams as predicted and advancing toward flow testing and commercial production.

Galan Lithium has finished commissioning at its Hombre Muerto West project in Argentina, processing its first lithium chloride and aiming for product sales in the second half of 2026. The company is also preparing to expand production capacity by 30% in early 2027.

Atomic Eagle has sharpened its uranium exploration focus at Muntanga North, Zambia, completing 53 of 80 planned line kilometres of ground radiometric surveys that confirm and refine large-scale anomalies. Drilling is set to begin imminently on these high-priority targets.

VRX Silica has kicked off a $6.23 million renounceable entitlement offer, underwritten to $2 million, to fund key development activities at its Arrowsmith North silica sand project including a strategic property purchase and engineering works.

Accelerate Resources has raised A$2 million in a two-tranche placement to fund aggressive exploration at its Balagundi Gold and Woodie Woodie North Manganese projects, aiming for a busy news flow through 2026.

Actinogen Medical has obtained positive scientific advice from the European Medicines Agency that aligns with prior FDA guidance, clarifying regulatory requirements for its Alzheimer’s drug Xanamem and paving the way for a streamlined approval process in major markets.

Terragen Holdings secures a landmark supply agreement for its probiotic and biostimulant products with Ravensworth Feedlot, alongside a $2.8 million funded trial at Mort & Co’s Grassdale feedlot to validate its probiotic’s impact on cattle performance.

Nexalis Therapeutics has locked in a $53 million non-dilutive funding facility with Point8 Capital, replacing its previous lender and supporting three clinical programs targeting breakthrough cancer pain, panic disorder, and treatment-resistant depression.

BPH Global Ltd (ASX: BP8) posted its second best monthly seaweed trading result with gross sales of approximately A$391,000 in the twelfth month, pushing aggregate sales beyond A$3.3 million as Indonesian operations scale up post-monsoon.

Imugene has dosed the first patient in a new cohort combining its azer-cel CAR T therapy with BTK inhibitors, targeting patients with B-cell malignancies who failed prior BTKi treatment. This move broadens the trial’s scope and tackles a significant unmet need in blood cancer therapy.

Develop Global’s Pioneer Dome lithium project hits high-grade infill drilling results surpassing resource expectations, setting the stage for a Final Investment Decision next month on an 850,000-tonne DSO operation.

Brightstar Resources has intersected visible gold in multiple deep diamond drillholes at Two Mile Hill, part of its Sandstone Gold Project. The drilling extends beyond 550m depth, underpinning plans for an underground mining study in the pre-feasibility study due later this year.